Anders Ullman

Dr. Ullman has served as a Non-Executive Director on the board of directors since September 2015.

Since January 2022, Dr. Ullman has served as Head of R&D and Chief Medical Officer of Sobi. From 2015 to 2018, he was Head of the COPD Centre at Sahlgrenska University Hospital, Sweden, and from 2013 to 2014, was Executive Vice President and Head of Research and Development in the BioScience business unit of Baxter International, a healthcare company that became Baxalta. From 2007 to 2013, Dr. Ullman was Executive Vice President, Head of Research and Development at Nycomed Pharma, which was acquired by Takeda Pharmaceutical. Dr. Ullman received an MD and a Ph.D. in clinical pharmacology from the University of Gothenburg.